Current Assets
Work in process
Moderna Work in process increased by 31.0% to $38M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.6%, from $39M to $38M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 26.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026
Parent metricInventories
Metric ID:
inv_work_in_progressHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $224M | $233M | $338M | $513M | $379M | $366M | $205M | $193M | $196M | $61M | $15M | $60M | $166M | $95M | $26M | $39M | $112M | $119M | $29M | $38M |
| QoQ Change | — | +4.0% | +45.1% | +51.8% | -26.1% | -3.4% | -44.0% | -5.9% | +1.6% | -68.9% | -75.4% | +300.0% | +176.7% | -42.8% | -72.6% | +50.0% | +187.2% | +6.3% | -75.6% | +31.0% |
| YoY Change | — | — | — | — | +69.2% | +57.1% | -39.3% | -62.4% | -48.3% | -83.3% | -92.7% | -68.9% | -15.3% | +55.7% | +73.3% | -35.0% | -32.5% | +25.3% | +11.5% | -2.6% |
| % of Inventories | 34.8% | 24.1% | 23.5% | 26.4% | 19.7% | 17.6% | 22.5% | 22.1% | 27.1% | 28.9% | 8.8% | 41.4% | 103.1% | 146.2% | 17.3% | 29.1% | 88.2% | 103.5% | 25.4% | 32.5% |
| Share Change | — | -10.7pp | -0.7pp | +3.0pp | -6.7pp | -2.1pp | +4.9pp | -0.4pp | +5.0pp | +1.8pp | -20.1pp | +32.6pp | +61.7pp | +43.0pp | -128.8pp | +11.8pp | +59.1pp | +15.3pp | -78.0pp | +7.0pp |
Range$15M – $513M
CAGR-31.2%
Avg YoY Growth-11.8%
Median YoY Growth-23.9%
Work in process at Other Companies
Frequently Asked Questions
- What is Moderna's work in process?
- Moderna (MRNA) reported work in process of $38M in Q1 2026.
- How has Moderna's work in process changed year-over-year?
- Moderna's work in process decreased by 2.6% year-over-year, from $39M to $38M.
- What is the long-term trend for Moderna's work in process?
- Over 5 years (2020 to 2025), Moderna's work in process has grown at a 26.4% compound annual growth rate (CAGR), from $9M to $29M.